Cas 890843-29-5,tert-butyl N-(1-bromoisoquinolin-3-yl)carbamate

890843-29-5

Post Buying Request

Basic information

Product Name: tert-butyl N-(1-bromoisoquinolin-3-yl)carbamate
Synonyms: tert-butyl N-(1-bromoisoquinolin-3-yl)carbamate
CAS NO:890843-29-5
Molecular Formula:
Molecular Weight: 323.189
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: tert-butyl N-(1-bromoisoquinolin-3-yl)carbamate(CAS DataBase Reference)
NIST Chemistry Reference: tert-butyl N-(1-bromoisoquinolin-3-yl)carbamate(890843-29-5)
EPA Substance Registry System: tert-butyl N-(1-bromoisoquinolin-3-yl)carbamate(890843-29-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 890843-29-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

890843-29-5 Suppliers

Recommended suppliers

890843-29-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 890843-29-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,0,8,4 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 890843-29:
(8*8)+(7*9)+(6*0)+(5*8)+(4*4)+(3*3)+(2*2)+(1*9)=205
205 % 10 = 5
So 890843-29-5 is a valid CAS Registry Number.

890843-29-5Upstream product

890843-29-5Downstream Products

890843-29-5Relevant academic research and scientific papers

KRAS G12C INHIBITORS

-

Paragraph 0259, (2020/03/23)

The present invention relates to compounds that, inhibit KRas G12C, In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

KRAS G12C INHIBITORS

-

Paragraph 0255, (2020/07/25)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

KRAS G12C INHIBITORS

-

Paragraph 0371-0372, (2019/05/24)

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

-

, (2018/07/15)

Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

-

Paragraph 0296, (2018/07/29)

KRAS G12C INHIBITORS AND METHODS OF USING THE SAME

-

Paragraph 0517, (2018/12/04)

KRAS G12C INHIBITORS

-

Paragraph 0227, (2017/12/18)

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 890843-29-5